Secondary proton buildup in space radiation shielding.

FLUKA Galactic cosmic ray spectrum Human space exploration Optically stimulated luminescence Secondary proton buildup Space radiation shielding

Journal

Life sciences in space research
ISSN: 2214-5532
Titre abrégé: Life Sci Space Res (Amst)
Pays: Netherlands
ID NLM: 101632373

Informations de publication

Date de publication:
May 2024
Historique:
received: 03 11 2023
revised: 06 02 2024
accepted: 15 02 2024
medline: 27 4 2024
pubmed: 27 4 2024
entrez: 26 4 2024
Statut: ppublish

Résumé

The risk posed by prolonged exposure to space radiation represents a significant obstacle to long-duration human space exploration. Of the ion species present in the galactic cosmic ray spectrum, relativistic protons are the most abundant and as such are a relevant point of interest with regard to the radiation protection of space crews involved in future long-term missions to the Moon, Mars, and beyond. This work compared the shielding effectiveness of a number of standard and composite materials relevant to the design and development of future spacecraft or planetary surface habitats. Absorbed dose was measured using Al

Identifiants

pubmed: 38670638
pii: S2214-5524(24)00024-5
doi: 10.1016/j.lssr.2024.02.005
pii:
doi:

Substances chimiques

Protons 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

119-126

Informations de copyright

Copyright © 2024 The Committee on Space Research (COSPAR). Published by Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

J M DeWitt (JM)

Department of Physics, East Carolina University, Greenville, NC 27834, USA. Electronic address: dewittjo@ecu.edu.

E R Benton (ER)

Department of Physics, Oklahoma State University, Stillwater, OK 74078, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH